WGU Advanced Pharmacology EXAM LATEST
2026/2027 ACTUAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+
Section 1: Pharmacokinetics & Pharmacodynamics (Questions 1–15)
,1. Which process describes the movement of a drug from its site of administration into the bloodstream?
- A) Distribution
- B) Metabolism
- C) Absorption
- D) Excretion
Answer: C
Rationale: Absorption is the first phase of pharmacokinetics and refers to the movement of drug from the site of
administration into systemic circulation. Distribution (A) is movement from blood to tissues; metabolism (B) is
biotransformation; excretion (D) is elimination.
2. A drug with a narrow therapeutic index requires:
- A) No monitoring
- B) Close monitoring of serum drug levels
- C) Higher doses for efficacy
- D) Less frequent dosing
,Answer: B
Rationale: A narrow therapeutic index means the difference between therapeutic and toxic doses is small. Serum level
monitoring helps maintain levels within the therapeutic range and avoid toxicity.
3. First-pass metabolism primarily occurs in the:
- A) Kidneys
- B) Liver
- C) Lungs
- D) Stomach
Answer: B
Rationale: First-pass metabolism occurs in the liver after oral absorption, where drugs are metabolized before reaching
systemic circulation. This reduces bioavailability of orally administered drugs.
4. Which route of administration bypasses first-pass metabolism?
- A) Oral
, - B) Rectal (partially)
- C) Intravenous
- D) Sublingual
Answer: C *(Note: Sublingual also bypasses first-pass; IV is the most complete bypass)*
Rationale: IV administration delivers drug directly into systemic circulation, completely bypassing hepatic first-pass
metabolism. Sublingual (D) also largely bypasses it, but IV is the definitive answer for complete bypass.
5. The half-life of a drug is the time required for:
- A) The drug to be completely eliminated
- B) Plasma concentration to decrease by 50%
- C) The drug to reach peak effect
- D) Steady state to be achieved
Answer: B
Rationale: Half-life (t½) is the time for plasma concentration to decrease by half. It takes approximately 4–5 half-lives to
reach steady state or near-complete elimination.
2026/2027 ACTUAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+
Section 1: Pharmacokinetics & Pharmacodynamics (Questions 1–15)
,1. Which process describes the movement of a drug from its site of administration into the bloodstream?
- A) Distribution
- B) Metabolism
- C) Absorption
- D) Excretion
Answer: C
Rationale: Absorption is the first phase of pharmacokinetics and refers to the movement of drug from the site of
administration into systemic circulation. Distribution (A) is movement from blood to tissues; metabolism (B) is
biotransformation; excretion (D) is elimination.
2. A drug with a narrow therapeutic index requires:
- A) No monitoring
- B) Close monitoring of serum drug levels
- C) Higher doses for efficacy
- D) Less frequent dosing
,Answer: B
Rationale: A narrow therapeutic index means the difference between therapeutic and toxic doses is small. Serum level
monitoring helps maintain levels within the therapeutic range and avoid toxicity.
3. First-pass metabolism primarily occurs in the:
- A) Kidneys
- B) Liver
- C) Lungs
- D) Stomach
Answer: B
Rationale: First-pass metabolism occurs in the liver after oral absorption, where drugs are metabolized before reaching
systemic circulation. This reduces bioavailability of orally administered drugs.
4. Which route of administration bypasses first-pass metabolism?
- A) Oral
, - B) Rectal (partially)
- C) Intravenous
- D) Sublingual
Answer: C *(Note: Sublingual also bypasses first-pass; IV is the most complete bypass)*
Rationale: IV administration delivers drug directly into systemic circulation, completely bypassing hepatic first-pass
metabolism. Sublingual (D) also largely bypasses it, but IV is the definitive answer for complete bypass.
5. The half-life of a drug is the time required for:
- A) The drug to be completely eliminated
- B) Plasma concentration to decrease by 50%
- C) The drug to reach peak effect
- D) Steady state to be achieved
Answer: B
Rationale: Half-life (t½) is the time for plasma concentration to decrease by half. It takes approximately 4–5 half-lives to
reach steady state or near-complete elimination.
